RxDoctor Payments Data

Robin Whitman

Nurse Practitioner · Encinitas, CANPI 1740205707

Payments from drug & device makers

$4,493in general payments, 2019–2025

Across 207 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$594
  • Merck$426
  • Pfizer$389
  • AstraZeneca$278
  • Amgen$266
  • Medtronic$240
  • plus $2K from 27 others

What the payments were for

  • Food & beverage$4,493100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,493 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban135$188,590
Repatha SureclickEvolocumab43$56,373
XareltoRivaroxaban39$40,887
Praluent PenAlirocumab40$35,609
EntrestoSacubitril/Valsartan11$7,439
Ezetimibe148$5,169
Metoprolol Succinate173$3,253
Atorvastatin Calcium215$2,930
Losartan Potassium141$1,984
Rosuvastatin Calcium144$1,944
Amlodipine Besylate204$1,768
Valsartan42$1,254
Flecainide Acetate17$1,078
Potassium Chloride45$916
ClopidogrelClopidogrel Bisulfate63$805

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$389$188,590135 claims
Johnson & JohnsonXarelto$198$40,88739 claims
NovartisEntresto$594$7,43911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in Encinitas

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →